MAHON PAUL A

PrivateCIK: 1231589

MAHON PAUL A (EVP & GENERAL COUNSEL) sold 18.4% of their position (8.30K shares) of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $4.01M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 6 sales
InsiderMAHON PAUL ACIK 1231589
IssuerUNITED THERAPEUTICS CORPCIK 1082554
Officer· EVP & GENERAL COUNSEL
Since Mar 2026
-8.30K
Net shares
Net seller
$4.01M
Total sold
6
Open market trades
0B · 6S
8
Total transactions
8.30K acquired · 16.60K disposed
Non-Derivative Transactions7

Common Stock

Direct
M · Option Exercise

Shares

+8.30K

Price / share

$146.03

Trade value

$1.21M

% of position

22.6%
2/5/2026
36.78K45.08K

Common Stock

Direct
S · Sale

Shares

477.00

Price / share

$480.92

Trade value

$229.40K

% of position

1.1%
2/5/2026
45.08K44.60K

Common Stock

Direct
S · Sale

Shares

2.36K

Price / share

$481.93

Trade value

$1.14M

% of position

5.3%
2/5/2026
44.60K42.24K

Common Stock

Direct
S · Sale

Shares

1.10K

Price / share

$482.57

Trade value

$532.27K

% of position

2.6%
2/5/2026
42.24K41.14K

Common Stock

Direct
S · Sale

Shares

2.75K

Price / share

$483.92

Trade value

$1.33M

% of position

6.7%
2/5/2026
41.14K38.39K

Common Stock

Direct
S · Sale

Shares

934.00

Price / share

$484.92

Trade value

$452.91K

% of position

2.4%
2/5/2026
38.39K37.46K

Common Stock

Direct
S · Sale

Shares

675.00

Price / share

$485.52

Trade value

$327.72K

% of position

1.8%
2/5/2026
37.46K36.78K
Total

Net shares

+0.00

Net value

-$2.80M

Derivative Transactions1

Stock Option

Direct
M · Option Exercise
Converts to

Common Stock

8.30K shares

Shares

8.30K

Strike price

146.03

Held after

50.10K

Exercisable

2/5/2026
MAHON PAUL A — Insider Transaction (Form 4) Filed Feb 5, 2026 | Finecho